Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard B Seeff

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|March 30, 2021
The 2020 Nobel Prize for Medicine or Physiology for the Discovery of Hepatitis C Virus: A Triumph of Curiosity and PersistenceMarc G Ghany, Anna S F Lok, Jules L Dienstag, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2010
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trialLeonard B Seeff, Gregory T Everson, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)|July 22, 2014
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury NetworkVictor J Navarro, Huiman Barnhart, Herbert L Bonkovsky, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 29, 2006
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantationNorah A Terrault, Mitchell L Shiffman, Anna S F Lok, et al.
Hepatology (Baltimore, Md.)|December 25, 2007
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) TrialLeonard B Seeff, Teresa M Curto, Gyongyi Szabo, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferonAdrian M Di Bisceglie, Anne M Stoddard, Jules L Dienstag, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trialGregory T Everson, John C Hoefs, Leonard B Seeff, et al.
Gastroenterology|October 14, 2008
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseAnna S Lok, Leonard B Seeff, Timothy R Morgan, et al.
Alimentary Pharmacology & Therapeutics|April 2, 2019
Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factorsAndrew Stolz, Victor Navarro, Paul H Hayashi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2021
Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver InjuryRaj Vuppalanchi, Herbert L Bonkovsky, Jawad Ahmad, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|March 30, 2021
The 2020 Nobel Prize for Medicine or Physiology for the Discovery of Hepatitis C Virus: A Triumph of Curiosity and PersistenceMarc G Ghany, Anna S F Lok, Jules L Dienstag, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2010
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trialLeonard B Seeff, Gregory T Everson, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)|July 22, 2014
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury NetworkVictor J Navarro, Huiman Barnhart, Herbert L Bonkovsky, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 29, 2006
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantationNorah A Terrault, Mitchell L Shiffman, Anna S F Lok, et al.
Hepatology (Baltimore, Md.)|December 25, 2007
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) TrialLeonard B Seeff, Teresa M Curto, Gyongyi Szabo, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferonAdrian M Di Bisceglie, Anne M Stoddard, Jules L Dienstag, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trialGregory T Everson, John C Hoefs, Leonard B Seeff, et al.
Gastroenterology|October 14, 2008
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseAnna S Lok, Leonard B Seeff, Timothy R Morgan, et al.
Alimentary Pharmacology & Therapeutics|April 2, 2019
Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factorsAndrew Stolz, Victor Navarro, Paul H Hayashi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2021
Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver InjuryRaj Vuppalanchi, Herbert L Bonkovsky, Jawad Ahmad, et al.
Pageof 5